Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna; Cresci, Sharon; Laguzzi, Federica; Vikström, Max; Richards, Mark; Pilbrow, Anna; Cameron, Vicky; Foco, Luisa; Doughty, Robert N.; Kuukasjärvi, Pekka; Allayee, Hooman; Hartiala, Jaana A.; Tang, W. H.Wilson; Lyytikäinen, Leo Pekka; Nikus, Kjell; Laurikka, Jari O.; Srinivasan, Sundararajan; Mordi, Ify R.; Trompet, Stella; Kraaijeveld, Adriaan; van Setten, Jessica; Gijsberts, Crystel M.; Maitland-van der Zee, Anke H.; Saely, Christoph H.; Gong, Yan; Johnson, Julie A.; Cooper-DeHoff, Rhonda M.; Pepine, Carl J.; Casu, Gavino; Leiherer, Andreas; Drexel, Heinz; Horne, Benjamin D.; van der Laan, Sander W.; Marziliano, Nicola; Hazen, Stanley L.; Sinisalo, Juha; Kähönen, Mika; Lehtimäki, Terho; Lang, Chim C.; Burkhardt, Ralph; Scholz, Markus; Jukema, J. Wouter; Eriksson, Niclas; Åkerblom, Axel; James, Stefan; Held, Claes; Hagström, Emil; Spertus, John A.; Algra, Ale; de Faire, Ulf; Åkesson, Agneta; Asselbergs, Folkert W.; Patel, Riyaz S.; Leander, Karin (23.06.2022)
article
Background: The knowledge of factors influencing disease progression in patients with established coronary heart disease (CHD) is still relatively limited. One potential pathway is related to peroxisome proliferator–activated ...